| Literature DB >> 36138366 |
Juan Diego Vargas-Murcia1, Sandra Patricia Isaza-Jaramillo2, Dionis Magnary Vallejo-Mesa2, Daniela Carvajal-Muñoz3.
Abstract
BACKGROUND: There is scarce information about ischemic stroke in young patients in Colombia. To get insights about this phenomenon, this study describes the etiologies and risk factors of ischemic stroke in young patients in a third level complexity referral hospital in Medellin, Colombia.Entities:
Keywords: Colombia; Etiology; Risk factors; Stroke; Young adult
Mesh:
Year: 2022 PMID: 36138366 PMCID: PMC9494873 DOI: 10.1186/s12883-022-02895-9
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.903
Characteristics of the subjects
| Characteristic | Descriptive statistic ( | |
|---|---|---|
| Absolute frequency | Relative frequency (%) | |
| Obesity | 30 | 12.7 |
| Dyslipidemia | 20 | 8.5 |
| Smoking | 70 | 29.5 |
| Arterial hypertension | 75 | 31.7 |
| Diabetes | 19 | 8.1 |
| Without Sleep apnea | 234 | 98.7 |
| Cancer | 7 | 3.0 |
| HIV | 2 | 0.8 |
| Syphilis | 3 | 1.3 |
| Alcohol intake | 55 | 23.2 |
| Marihuana | 21 | 8.9 |
| Cocaine | 23 | 9.7 |
| Other substances | 8 | 3.4 |
| Use of oral contraceptives | 9 | 3.8 |
| Postpartum | 2 | 0.8 |
| Ischemic cardiac disease | 7 | 3.0 |
| Heart failure | 14 | 5.9 |
| Peripheral arterial disease | 3 | 1.3 |
| Previous ischemic stroke | 30 | 12.6 |
| Family history of ischemic stroke | 20 | 8.4 |
| Valvular AF | 2 | 0.8 |
| Non valvular AF | 1 | 0.4 |
| Valve replacement | 12 | 5.0 |
| Without PFO | 233 | 98.3 |
| Without ASA | 233 | 98.3 |
| Low levels of Vitamin B12 | 27 | 11.4 |
| Migraine | 22 | 9.2 |
| APS | 2 | 0.8 |
| SLE | 8 | 3.4 |
| Anticardiolipin antibodies | 17 | 7.2 |
| Lupus anticoagulant | 18 | 7.6 |
| PC deficiency | 3 | 1.3 |
| PS deficiency | 7 | 3.0 |
| Hyperhomocysteinemia | 4 | 1.7 |
| Factor V Leiden | 1 | 0.4 |
| Without Prothrombin deficiency | 7 | 3.0 |
| Other thrombophilia (AT-III deficiency) | 1 | 0.4 |
| Craniocervical arterial dissection | 28 | 11.8 |
| Large-artery atherosclerosis | 17 | 7.2 |
| Small-vessel disease | 16 | 6.8 |
| Substance abuse | 11 | 4.6 |
| PFO | 11 | 4.6 |
| Valve replacement | 11 | 4.6 |
| Dilated cardiomyopathy (ejection fraction < 35%) | 10 | 4.2 |
| Atrial fibrillation | 8 | 3.4 |
| Intracardiac thrombi | 6 | 2.5 |
| APS | 5 | 2.1 |
| Rheumatic cardiac disease | 4 | 1.7 |
| Central nervous system primary vasculitis | 3 | 1.3 |
| Infectious endocarditis | 3 | 1.3 |
| PFO + ASA | 3 | 1.3 |
| Moyamoya syndrome | 3 | 1.3 |
| Reversible cerebral vasoconstriction syndrome | 3 | 1.3 |
| Left ventricle hypokinesis | 2 | 0.8 |
| Tuberculous vasculitis | 2 | 0.8 |
| Meningovascular syphilis | 2 | 0.8 |
| CADASIL | 1 | 0.4 |
| Fibromuscular dysplasia | 1 | 0.4 |
| Hypercoagulability secondary to HIV | 1 | 0.4 |
| Hypercoagulability secondary to nephrotic syndrome (primary glomerulonephritis) | 1 | 0.4 |
| Hypercoagulability secondary to nephrotic syndrome (Diabetic nephropathy) | 1 | 0.4 |
| Hypoperfusion post cardiac arrest post | 1 | 0.4 |
| Acute myocardial infarction | 1 | 0.4 |
| Heart failure | 1 | 0.4 |
| Irregularity of intracerebral vessels | 1 | 0.4 |
| Paraneoplastic hypercoagulability syndrome | 1 | 0.4 |
| Thrombophilia (protein S deficiency) | 1 | 0.4 |
| Vasculitis | 1 | 0.4 |
| Acquired thrombophilia (protein S deficiency, protein C and ATIII) | 1 | 0.4 |
| SLE vasculitis | 1 | 0.4 |
| Toxic vasculitis secondary to cocaine abuse | 1 | 0.4 |
AF Atrial fibrillation, APS Antiphospholipid syndrome, ASA Atrial septal aneurysm, AT-III Antithrombin III, HIV Human immunodeficiency virus, PC: protein C, PFO Patent foramen ovale, PS Protein S, SLE Systemic lupus erythematosus
Frequency of cardioembolic causes (n = 42)
| High risk sources | Na | % |
|---|---|---|
| Dilated cardiomyopathy (ejection fraction < 35%) | 9 | 21.43 |
| Intracardiac thrombi | 6 | 14.29 |
| Infectious endocarditis | 2 | 4.76 |
| Rheumatic cardiac disease | 4 | 9.52 |
| Atrial fibrillation | 6 | 14.29 |
| Acute myocardial infarction | 1 | 2.38 |
| Valve replacement | 10 | 23.81 |
| Moderate risk sources | N | % |
| Left ventricle hypokinesis | 2 | 4.76 |
| Heart failure | 1 | 2.38 |
| Patent foramen ovale | 8 | 19.05 |
| Patent foramen ovale + atrial septal aneurysm | 3 | 7.14 |
a The number of causes is higher than the total number of subjects due to some subjects having more than one cardioembolic source
Frequency of causes classified as other determined causes (n = 61)
| N | % | |
|---|---|---|
| Substance abuse | 7 | 11.48 |
| Craniocervical arterial dissection | 27 | 44.26 |
| Fibromuscular dysplasia | 1 | 1.64 |
| Hypercoagulability secondary to nephrotic syndrome (primary glomerulonephritis) | 1 | 1.64 |
| Hypercoagulability secondary to nephrotic syndrome (Diabetic nephropathy) | 1 | 1.64 |
| Hypoperfusion post cardiac arrest post | 1 | 1.64 |
| Meningovascular syphilis | 2 | 3.28 |
| APS | 5 | 8.20 |
| Paraneoplastic hypercoagulability syndrome | 1 | 1.64 |
| Moyamoya syndrome | 3 | 4.92 |
| Reversible cerebral vasoconstriction syndrome | 2 | 3.28 |
| Thrombophilia (protein S deficiency) | 1 | 1.64 |
| Acquired thrombophilia (protein S deficiency, protein C and ATIII) | 1 | 1.64 |
| Vasculitis | 1 | 1.64 |
| SLE vasculitis | 1 | 1.64 |
| Central nervous system primary vasculitis | 3 | 4.92 |
| Toxic vasculitis secondary to cocaine abuse | 1 | 1.64 |
| Tuberculous vasculitis | 2 | 3.28 |
APS Antiphospholipid syndrome
AT-III Antithrombin III
SLE Systemic lupus erythematosus
Fig. 1Traditional cardiovascular risk factors by sex and age group. Traditional cardiovascular risk factors: Obesity, dyslipidemia, arterial hypertension, diabetes, smoking. * Modified from: Maaijwee NA, et al. Ischaemic stroke in young adults: risk factors and long-term consequences. Nature Reviews Neurology. 2018 [16]
Fig. 2TOAST category by age group. * Modified from: Putaala J, et al. Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke. The Helsinki Young Stroke Registry. Stroke. 2009 [7]